Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


29.10.2018

1 Am Heart J
5 Am J Cardiol
2 Ann Thorac Surg
1 BMJ
17 Circ Arrhythm Electrophysiol
2 Circ Cardiovasc Imaging
1 Circ Genom Precis Med
2 Circ Heart Fail
12 Circulation
1 Eur Heart J
11 Int J Cardiol
2 J Am Coll Cardiol
1 J Cardiovasc Electrophysiol
1 J Electrocardiol
3 J Interv Card Electrophysiol
1 J Thorac Cardiovasc Surg
5 Pacing Clin Electrophysiol
4 Stroke


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. ANDRADE JG, Champagne J, Deyell MW, Essebag V, et al
    A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale.
    Am Heart J. 2018;206:94-104.
    PubMed     Text format     Abstract available


    Am J Cardiol

  2. ALDAAS OM, Malladi CL, Hsu JC
    Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure.
    Am J Cardiol. 2018 Sep 26. pii: S0002-9149(18)31834.
    PubMed     Text format     Abstract available

  3. MELLES MC, Yap SC, Bhagwandien RE, Sakhi R, et al
    Frequency of Need for Antitachycardia or Antibradycardia Pacing or Cardiac Resynchronization Therapy in Patients With a Single-Chamber Implantable Cardioverter-Defibrillator.
    Am J Cardiol. 2018 Sep 23. pii: S0002-9149(18)31764.
    PubMed     Text format     Abstract available

  4. NIKU AD, Shiota T, Siegel RJ, Rader F, et al
    Prevalence and Resolution of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation and Flutter With Oral Anticoagulation.
    Am J Cardiol. 2018 Sep 26. pii: S0002-9149(18)31848.
    PubMed     Text format     Abstract available

  5. CANPOLAT U, Aytemir K
    Epicardial Fat As an Indicator of the Metabolic Syndrome Promoting Atrial Fibrillation Recurrence.
    Am J Cardiol. 2018 Sep 26. pii: S0002-9149(18)31855.
    PubMed     Text format    

  6. KUO L, Chao TF, Liu CJ, Chen SJ, et al
    Usefulness of the CHA2DS2-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation.
    Am J Cardiol. 2018 Sep 13. pii: S0002-9149(18)31761.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  7. KRISHNAN A, Suarez-Pierre A, Crawford TC, Zhou X, et al
    Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia.
    Ann Thorac Surg. 2018;105:e51-e53.
    PubMed     Text format     Abstract available

  8. HALL EJ, Smith AH, Fish FA, Bichell DP, et al
    Association of Shunt Type With Arrhythmias After Norwood Procedure.
    Ann Thorac Surg. 2018;105:629-636.
    PubMed     Text format     Abstract available


    BMJ

  9. ZUNGSONTIPORN N, Link MS
    Newer technologies for detection of atrial fibrillation.
    BMJ. 2018;363:k3946.
    PubMed     Text format     Abstract available


    Circ Arrhythm Electrophysiol

  10. HUSSEIN A, Das M, Riva S, Morgan M, et al
    Use of Ablation Index-Guided Ablation Results in High Rates of Durable Pulmonary Vein Isolation and Freedom From Arrhythmia in Persistent Atrial Fibrillation Patients.
    Circ Arrhythm Electrophysiol. 2018;11:e006576.
    PubMed     Text format     Abstract available

  11. BASKAR S, Bao H, Minges KE, Spar DS, et al
    Characteristics and Outcomes of Pediatric Patients Who Undergo Placement of Implantable Cardioverter Defibrillators.
    Circ Arrhythm Electrophysiol. 2018;11:e006542.
    PubMed     Text format     Abstract available

  12. STAVRAKIS S, Jackman WM, Lockwood D, Nakagawa H, et al
    Slow/Fast Atrioventricular Nodal Reentrant Tachycardia Using the Inferolateral Left Atrial Slow Pathway.
    Circ Arrhythm Electrophysiol. 2018;11:e006631.
    PubMed     Text format     Abstract available

  13. TALIB AK, Takagi M, Shimane A, Nakano M, et al
    Efficacy of Endocardial Ablation of Drug-Resistant Ventricular Fibrillation in Brugada Syndrome.
    Circ Arrhythm Electrophysiol. 2018;11:e005631.
    PubMed     Text format     Abstract available

  14. NORDENSWAN HK, Lehtonen J, Ekstrom K, Kandolin R, et al
    Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.
    Circ Arrhythm Electrophysiol. 2018;11:e006145.
    PubMed     Text format     Abstract available

  15. WITT CM, Waks JW, Mehta RA, Friedman PA, et al
    Risk of Appropriate Therapy and Death Before Therapy After Implantable Cardioverter-Defibrillator Generator Replacement.
    Circ Arrhythm Electrophysiol. 2018;11:e006155.
    PubMed     Text format     Abstract available

  16. LEVINE BD
    Response by Levine to Letter Regarding Article, "Does High-Intensity Endurance Training Increase the Risk of Atrial Fibrillation? A Longitudinal Study of Left Atrial Structure and Function".
    Circ Arrhythm Electrophysiol. 2018;11:e006651.
    PubMed     Text format    


  17. Correction to: Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Subsequent Risk of Emergency Department Visits and Hospitalizations for Atrial Fibrillation.
    Circ Arrhythm Electrophysiol. 2018;11:e000033.
    PubMed     Text format    

  18. ADIYAMAN A, Buist TJ, Beukema RJ, Smit JJJ, et al
    Randomized Controlled Trial of Surgical Versus Catheter Ablation for Paroxysmal and Early Persistent Atrial Fibrillation.
    Circ Arrhythm Electrophysiol. 2018;11:e006182.
    PubMed     Text format     Abstract available

  19. PODZIEMSKI P, Zeemering S, Kuklik P, van Hunnik A, et al
    Rotors Detected by Phase Analysis of Filtered, Epicardial Atrial Fibrillation Electrograms Colocalize With Regions of Conduction Block.
    Circ Arrhythm Electrophysiol. 2018;11:e005858.
    PubMed     Text format     Abstract available

  20. DUPREZ DA, Heckbert SR, Alonso A, Gross MD, et al
    Collagen Biomarkers and Incidence of New Onset of Atrial Fibrillation in Subjects With No Overt Cardiovascular Disease at Baseline.
    Circ Arrhythm Electrophysiol. 2018;11:e006557.
    PubMed     Text format     Abstract available

  21. BIRNIE D, Ha A, Kron J
    Which Patients With Cardiac Sarcoidosis Should Receive Implantable Cardioverter-Defibrillators.
    Circ Arrhythm Electrophysiol. 2018;11:e006685.
    PubMed     Text format    


  22. Correction to: Unraveling the Underlying Arrhythmia: Mechanism in Persistent Atrial Fibrillation: Results From the STARLIGHT Study.
    Circ Arrhythm Electrophysiol. 2018;11:e000030.
    PubMed     Text format    


  23. Correction to: Comprehensive Multicenter Study of the Common Isthmus in Post-Atrial Fibrillation Ablation Multiple-Loop Atrial Tachycardia.
    Circ Arrhythm Electrophysiol. 2018;11:e000032.
    PubMed     Text format    


  24. Correction to: Hot Balloon Versus Cryoballoon Ablation for Atrial Fibrillation: Lesion Characteristics and Middle-Term Outcomes.
    Circ Arrhythm Electrophysiol. 2018;11:e000028.
    PubMed     Text format    

  25. BANKS L, Goodman JM, Dorian P
    Letter by Banks et al Regarding Article, "Does High-Intensity Endurance Training Increase the Risk of Atrial Fibrillation? A Longitudinal Study of Left Atrial Structure and Function".
    Circ Arrhythm Electrophysiol. 2018;11:e006645.
    PubMed     Text format    

  26. HIRAYAMA A, Goto T, Shimada YJ, Faridi MK, et al
    Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Subsequent Risk of Emergency Department Visits and Hospitalizations for Atrial Fibrillation.
    Circ Arrhythm Electrophysiol. 2018;11:e006322.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Imaging

  27. ZGHAIB T, Ghasabeh MA, Assis FR, Chrispin J, et al
    Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circ Cardiovasc Imaging. 2018;11:e007546.
    PubMed     Text format     Abstract available

  28. ZGHAIB T, Bourfiss M, van der Heijden JF, Loh P, et al
    Atrial Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circ Cardiovasc Imaging. 2018;11:e007344.
    PubMed     Text format     Abstract available


    Circ Genom Precis Med

  29. ZAHAVICH L, Tarnopolsky M, Yao R, Mital S, et al
    Novel Association of a De Novo CALM2 Mutation With Long QT Syndrome and Hypertrophic Cardiomyopathy.
    Circ Genom Precis Med. 2018;11:e002255.
    PubMed     Text format    


    Circ Heart Fail

  30. LEE SP, Ashley EA, Homburger J, Caleshu C, et al
    Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
    Circ Heart Fail. 2018;11:e005191.
    PubMed     Text format     Abstract available

  31. LUO N, Xu H, Jneid H, Fonarow GC, et al
    Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation.
    Circ Heart Fail. 2018;11:e005356.
    PubMed     Text format     Abstract available


    Circulation

  32. OKADA DR, Smith J, Derakhshan A, Gowani Z, et al
    Ventricular Arrhythmias in Cardiac Sarcoidosis.
    Circulation. 2018;138:1253-1264.
    PubMed     Text format     Abstract available


  33. Correction to: 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Cl
    Circulation. 2018;138:e415-e418.
    PubMed     Text format    


  34. Correction to: Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Forc
    Circulation. 2018;138:e421.
    PubMed     Text format    


  35. Correction to: 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Gui
    Circulation. 2018;138:e419-e420.
    PubMed     Text format    

  36. CHAO TF, Chiang CE, Lin YJ, Chang SL, et al
    Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan.
    Circulation. 2018;138:1485-1487.
    PubMed     Text format    

  37. TONG S, Zhang L, Joseph J
    Letter by Tong et al Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials".
    Circulation. 2018;138:1277-1278.
    PubMed     Text format    

  38. DE VEER AJWM, Bennaghmouch N, Mahmoodi BK, Ten Berg JM, et al
    Response by de Veer et al to Letter Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Tria
    Circulation. 2018;138:1279.
    PubMed     Text format    


  39. Correction to: Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States.
    Circulation. 2018;138:e425.
    PubMed     Text format    

  40. MARTIN AC, Godier A, Narayanan K, Smadja DM, et al
    Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation.
    Circulation. 2018;138:627-633.
    PubMed     Text format     Abstract available

  41. SARRIAS A, Bayes-Genis A
    Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug?
    Circulation. 2018;138:551-553.
    PubMed     Text format    


  42. Correction to: Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2018;138:e123.
    PubMed     Text format    

  43. LEI M, Wu L, Terrar DA, Huang CL, et al
    Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Circulation. 2018;138:1879-1896.
    PubMed     Text format     Abstract available


    Eur Heart J

  44. BOERSMA LVA
    Biventricular pacing after AV-node ablation for atrial fibrillation with heart failure: something old and something new, future standard, or just for the few?
    Eur Heart J. 2018 Oct 25. pii: 5145027. doi: 10.1093.
    PubMed     Text format    


    Int J Cardiol

  45. SHULMAN E, Chudow JJ, Essien UR, Shanbhag A, et al
    Relative contribution of modifiable risk factors for incident atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites.
    Int J Cardiol. 2018 Oct 10. pii: S0167-5273(18)35024.
    PubMed     Text format     Abstract available

  46. MOON I, Choi EK, Jung JH, Han KD, et al
    Ankylosing spondylitis: A novel risk factor for atrial fibrillation - A nationwide population-based study.
    Int J Cardiol. 2018 Oct 11. pii: S0167-5273(18)34136.
    PubMed     Text format     Abstract available

  47. LAMBIASE PD
    AF stroke risk stratification-can we do better?
    Int J Cardiol. 2018;257:108-109.
    PubMed     Text format    

  48. CALLOE K, Broendberg AK, Christensen AH, Pedersen LN, et al
    Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Nav1.5 gain-of-function mutation (G213D).
    Int J Cardiol. 2018;257:160-167.
    PubMed     Text format     Abstract available

  49. LIU S, Guan Z, Zheng X, Meng P, et al
    Impaired left atrial systolic function and inter-atrial dyssynchrony may contribute to symptoms of heart failure with preserved left ventricular ejection fraction: A comprehensive assessment by echocardiography.
    Int J Cardiol. 2018;257:177-181.
    PubMed     Text format     Abstract available

  50. OLIVOTTO I, Finocchiaro G, Maurizi N, Crotti L, et al
    Common presentation of rare cardiac diseases: Arrhythmias.
    Int J Cardiol. 2018;257:351-357.
    PubMed     Text format     Abstract available

  51. YANG H, Heidendael JF, de Groot JR, Konings TC, et al
    Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines.
    Int J Cardiol. 2018;257:67-74.
    PubMed     Text format     Abstract available

  52. JIA X, Levine GN, Birnbaum Y
    The CHA2DS2-VASc score: Not as simple as it seems.
    Int J Cardiol. 2018;257:92-96.
    PubMed     Text format     Abstract available

  53. YU P, Hu L, Xie J, Chen S, et al
    O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts.
    Int J Cardiol. 2018;260:74-81.
    PubMed     Text format     Abstract available

  54. YE Y, Zhang Z, Sheng X, Wang B, et al
    Upgrade to his bundle pacing in pacing-dependent patients referred for pulse generator change: Feasibility and intermediate term follow up.
    Int J Cardiol. 2018;260:88-92.
    PubMed     Text format     Abstract available

  55. PENELA D, Mont L
    VT ablation and survival: A solved question?
    Int J Cardiol. 2018;267:118-119.
    PubMed     Text format    


    J Am Coll Cardiol

  56. BUTT JH, Olesen JB, Havers-Borgersen E, Gundlund A, et al
    Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac Surgery.
    J Am Coll Cardiol. 2018;72:2027-2036.
    PubMed     Text format     Abstract available

  57. CURTIS AB, Khan HA
    Should All Atrial Fibrillation Be Considered a Life-Long Problem Requiring Prophylaxis Against Thromboembolism?
    J Am Coll Cardiol. 2018;72:2037-2039.
    PubMed     Text format    


    J Cardiovasc Electrophysiol

  58. SCHADE A, Costello-Boerrigter L, Deneke T
    Mapping of persistent atrial fibrillation: Learning to walk, step by step.
    J Cardiovasc Electrophysiol. 2018 Oct 18. doi: 10.1111/jce.13730.
    PubMed     Text format    


    J Electrocardiol

  59. MARQUEZ MF
    Repolarization time in presence of intraventricular conduction disturbances. A new solution for an old problem.
    J Electrocardiol. 2018;51:559-560.
    PubMed     Text format    


    J Interv Card Electrophysiol

  60. WEI Y, Zhang N, Jin Q, Pan W, et al
    Comparison of efficacy and safety of laser balloon and cryoballoon ablation for atrial fibrillation-a meta-analysis.
    J Interv Card Electrophysiol. 2018 Oct 20. pii: 10.1007/s10840-018-0474.
    PubMed     Text format     Abstract available

  61. NAKSUK N, Sugrue AM, Padmanabhan D, Kella D, et al
    Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
    J Interv Card Electrophysiol. 2018 Oct 23. pii: 10.1007/s10840-018-0476.
    PubMed     Text format     Abstract available

  62. BULLERT KG, Gutleben KJ, Horstkotte D, Fischbach T, et al
    Hemoptysis as a side effect of cryoballoon pulmonary vein isolation in atrial fibrillation: a retrospective case-control study.
    J Interv Card Electrophysiol. 2018 Oct 25. pii: 10.1007/s10840-018-0468.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  63. ZEHR KJ
    What can we learn from a novel "Global Positioning System" in persistent atrial fibrillation?
    J Thorac Cardiovasc Surg. 2018 Sep 15. pii: S0022-5223(18)32343.
    PubMed     Text format    


    Pacing Clin Electrophysiol

  64. ZHOU W, Wang L, Zhou B, Wu L, et al
    Catheter ablation of paroxysmal atrial fibrillation using high-density mapping-guided substrate modification.
    Pacing Clin Electrophysiol. 2018 Oct 24. doi: 10.1111/pace.13524.
    PubMed     Text format     Abstract available

  65. OSMAN M, Ahmed A, Alzubi H, Kheiri B, et al
    Association between changes in the intrathoracic impedance and ventricular arrhythmias in patients with heart failure.
    Pacing Clin Electrophysiol. 2018 Oct 25. doi: 10.1111/pace.13535.
    PubMed     Text format     Abstract available

  66. ABOU HASSAN OK, Refaat MM
    Changes in intrathoracic impedance and episodes of ventricular arrhythmias in patients with heart failure and reduced ejection fraction.
    Pacing Clin Electrophysiol. 2018 Oct 26. doi: 10.1111/pace.13536.
    PubMed     Text format    

  67. ANTZELEVITCH C, Viskin S
    Should theophylline be added to the J wave syndrome therapeutic armamentarium?
    Pacing Clin Electrophysiol. 2018;41:439-440.
    PubMed     Text format    

  68. ALTURKI A, Proietti R
    Remote magnetic navigation versus contact force technology: The two faces of the ablation lesion.
    Pacing Clin Electrophysiol. 2018;41:447-449.
    PubMed     Text format    


    Stroke

  69. WITSCH J, Merkler AE, Chen ML, Navi BB, et al
    Incidence of Atrial Fibrillation in Patients With Recent Ischemic Stroke Versus Matched Controls.
    Stroke. 2018;49:2529-2531.
    PubMed     Text format     Abstract available

  70. OGAWA H, An Y, Ikeda S, Aono Y, et al
    Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events.
    Stroke. 2018;49:2301-2308.
    PubMed     Text format     Abstract available

  71. YU HT, Yang PS, Kim TH, Jang E, et al
    Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation.
    Stroke. 2018;49:2421-2429.
    PubMed     Text format     Abstract available

  72. FORSLUND T, Komen JJ, Andersen M, Wettermark B, et al
    Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants.
    Stroke. 2018;49:2122-2128.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: